The global Recombinant Human Insulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Recombinant Human Insulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Recombinant Human Insulin include Akron Biotech, Wockhardt, Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories and Dongbro Pharmaceuticri, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Recombinant Human Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Recombinant Human Insulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant Human Insulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Human Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Human Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Human Insulin sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Recombinant Human Insulin Market Report

Report Metric	Details
Report Name	Recombinant Human Insulin Market
Segment by Type	by Recombinant DNA Technology Using Fermentation in Bacteria Way by Recombinant DNA Technology Using Fermentation in Yeast Way
Segment by Application	Type 1 Diabetes Mellitus Type 2 Diabetes Mellitus
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories, Dongbro Pharmaceuticri
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant Human Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Insulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Human Insulin Market report?

Ans: The main players in the Recombinant Human Insulin Market are Dance Biopharm, Novo Nordisk, Gan & Lee, United Laboratories, Dongbro Pharmaceuticri

What are the Application segmentation covered in the Recombinant Human Insulin Market report?

Ans: The Applications covered in the Recombinant Human Insulin Market report are Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

What are the Type segmentation covered in the Recombinant Human Insulin Market report?

Ans: The Types covered in the Recombinant Human Insulin Market report are by Recombinant DNA Technology Using Fermentation in Bacteria Way, by Recombinant DNA Technology Using Fermentation in Yeast Way

1 Study Coverage

1.1 Recombinant Human Insulin Product Introduction

1.2 Market by Type

1.2.1 Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 by Recombinant DNA Technology Using Fermentation in Bacteria Way

1.2.3 by Recombinant DNA Technology Using Fermentation in Yeast Way

1.3 Market by Application

1.3.1 Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Type 1 Diabetes Mellitus

1.3.3 Type 2 Diabetes Mellitus

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030

2.2 Global Recombinant Human Insulin Revenue by Region

2.2.1 Global Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Recombinant Human Insulin Revenue by Region (2019-2024)

2.2.3 Global Recombinant Human Insulin Revenue by Region (2025-2030)

2.2.4 Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)

2.3 Global Recombinant Human Insulin Sales Estimates and Forecasts 2019-2030

2.4 Global Recombinant Human Insulin Sales by Region

2.4.1 Global Recombinant Human Insulin Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Recombinant Human Insulin Sales by Region (2019-2024)

2.4.3 Global Recombinant Human Insulin Sales by Region (2025-2030)

2.4.4 Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Recombinant Human Insulin Sales by Manufacturers

3.1.1 Global Recombinant Human Insulin Sales by Manufacturers (2019-2024)

3.1.2 Global Recombinant Human Insulin Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Insulin in 2023

3.2 Global Recombinant Human Insulin Revenue by Manufacturers

3.2.1 Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024)

3.2.2 Global Recombinant Human Insulin Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Insulin Revenue in 2023

3.3 Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Recombinant Human Insulin Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application

3.8 Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Recombinant Human Insulin Sales by Type

4.1.1 Global Recombinant Human Insulin Historical Sales by Type (2019-2024)

4.1.2 Global Recombinant Human Insulin Forecasted Sales by Type (2025-2030)

4.1.3 Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)

4.2 Global Recombinant Human Insulin Revenue by Type

4.2.1 Global Recombinant Human Insulin Historical Revenue by Type (2019-2024)

4.2.2 Global Recombinant Human Insulin Forecasted Revenue by Type (2025-2030)

4.2.3 Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

4.3 Global Recombinant Human Insulin Price by Type

4.3.1 Global Recombinant Human Insulin Price by Type (2019-2024)

4.3.2 Global Recombinant Human Insulin Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Recombinant Human Insulin Sales by Application

5.1.1 Global Recombinant Human Insulin Historical Sales by Application (2019-2024)

5.1.2 Global Recombinant Human Insulin Forecasted Sales by Application (2025-2030)

5.1.3 Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)

5.2 Global Recombinant Human Insulin Revenue by Application

5.2.1 Global Recombinant Human Insulin Historical Revenue by Application (2019-2024)

5.2.2 Global Recombinant Human Insulin Forecasted Revenue by Application (2025-2030)

5.2.3 Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

5.3 Global Recombinant Human Insulin Price by Application

5.3.1 Global Recombinant Human Insulin Price by Application (2019-2024)

5.3.2 Global Recombinant Human Insulin Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Recombinant Human Insulin Market Size by Type

6.1.1 US & Canada Recombinant Human Insulin Sales by Type (2019-2030)

6.1.2 US & Canada Recombinant Human Insulin Revenue by Type (2019-2030)

6.2 US & Canada Recombinant Human Insulin Market Size by Application

6.2.1 US & Canada Recombinant Human Insulin Sales by Application (2019-2030)

6.2.2 US & Canada Recombinant Human Insulin Revenue by Application (2019-2030)

6.3 US & Canada Recombinant Human Insulin Market Size by Country

6.3.1 US & Canada Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Recombinant Human Insulin Sales by Country (2019-2030)

6.3.3 US & Canada Recombinant Human Insulin Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Recombinant Human Insulin Market Size by Type

7.1.1 Europe Recombinant Human Insulin Sales by Type (2019-2030)

7.1.2 Europe Recombinant Human Insulin Revenue by Type (2019-2030)

7.2 Europe Recombinant Human Insulin Market Size by Application

7.2.1 Europe Recombinant Human Insulin Sales by Application (2019-2030)

7.2.2 Europe Recombinant Human Insulin Revenue by Application (2019-2030)

7.3 Europe Recombinant Human Insulin Market Size by Country

7.3.1 Europe Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Recombinant Human Insulin Sales by Country (2019-2030)

7.3.3 Europe Recombinant Human Insulin Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Recombinant Human Insulin Market Size

8.1.1 China Recombinant Human Insulin Sales (2019-2030)

8.1.2 China Recombinant Human Insulin Revenue (2019-2030)

8.2 China Recombinant Human Insulin Market Size by Application

8.2.1 China Recombinant Human Insulin Sales by Application (2019-2030)

8.2.2 China Recombinant Human Insulin Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Recombinant Human Insulin Market Size by Type

9.1.1 Asia Recombinant Human Insulin Sales by Type (2019-2030)

9.1.2 Asia Recombinant Human Insulin Revenue by Type (2019-2030)

9.2 Asia Recombinant Human Insulin Market Size by Application

9.2.1 Asia Recombinant Human Insulin Sales by Application (2019-2030)

9.2.2 Asia Recombinant Human Insulin Revenue by Application (2019-2030)

9.3 Asia Recombinant Human Insulin Sales by Region

9.3.1 Asia Recombinant Human Insulin Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Recombinant Human Insulin Revenue by Region (2019-2030)

9.3.3 Asia Recombinant Human Insulin Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Type

10.1.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Recombinant Human Insulin Market Size by Application

10.2.1 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country

10.3.1 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Akron Biotech

11.1.1 Akron Biotech Company Information

11.1.2 Akron Biotech Overview

11.1.3 Akron Biotech Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Akron Biotech Recent Developments

11.2 Wockhardt

11.2.1 Wockhardt Company Information

11.2.2 Wockhardt Overview

11.2.3 Wockhardt Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Wockhardt Recent Developments

11.3 Dance Biopharm

11.3.1 Dance Biopharm Company Information

11.3.2 Dance Biopharm Overview

11.3.3 Dance Biopharm Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Dance Biopharm Recent Developments

11.4 Novo Nordisk

11.4.1 Novo Nordisk Company Information

11.4.2 Novo Nordisk Overview

11.4.3 Novo Nordisk Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Novo Nordisk Recent Developments

11.5 Gan & Lee

11.5.1 Gan & Lee Company Information

11.5.2 Gan & Lee Overview

11.5.3 Gan & Lee Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Gan & Lee Recent Developments

11.6 United Laboratories

11.6.1 United Laboratories Company Information

11.6.2 United Laboratories Overview

11.6.3 United Laboratories Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 United Laboratories Recent Developments

11.7 Dongbro Pharmaceuticri

11.7.1 Dongbro Pharmaceuticri Company Information

11.7.2 Dongbro Pharmaceuticri Overview

11.7.3 Dongbro Pharmaceuticri Recombinant Human Insulin Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Dongbro Pharmaceuticri Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Recombinant Human Insulin Industry Chain Analysis

12.2 Recombinant Human Insulin Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Recombinant Human Insulin Production Mode & Process

12.4 Recombinant Human Insulin Sales and Marketing

12.4.1 Recombinant Human Insulin Sales Channels

12.4.2 Recombinant Human Insulin Distributors

12.5 Recombinant Human Insulin Customers

13 Market Dynamics

13.1 Recombinant Human Insulin Industry Trends

13.2 Recombinant Human Insulin Market Drivers

13.3 Recombinant Human Insulin Market Challenges

13.4 Recombinant Human Insulin Market Restraints

14 Key Findings in The Global Recombinant Human Insulin Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Dongbro Pharmaceuticri

List of Tables

Table 1. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Type I

Table 3. Major Manufacturers of Type II

Table 4. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Recombinant Human Insulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2024)

Table 9. Global Recombinant Human Insulin Revenue Market Share by Region (2025-2030)

Table 10. Global Recombinant Human Insulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Recombinant Human Insulin Sales by Region (2019-2024) & (g)

Table 12. Global Recombinant Human Insulin Sales by Region (2025-2030) & (g)

Table 13. Global Recombinant Human Insulin Sales Market Share by Region (2019-2024)

Table 14. Global Recombinant Human Insulin Sales Market Share by Region (2025-2030)

Table 15. Global Recombinant Human Insulin Sales by Manufacturers (2019-2024) & (g)

Table 16. Global Recombinant Human Insulin Sales Share by Manufacturers (2019-2024)

Table 17. Global Recombinant Human Insulin Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Recombinant Human Insulin Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Recombinant Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Recombinant Human Insulin Price by Manufacturers 2019-2024 (USD/mg)

Table 21. Global Recombinant Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Recombinant Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Insulin as of 2023)

Table 23. Global Key Manufacturers of Recombinant Human Insulin, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Recombinant Human Insulin, Product Offered and Application

Table 25. Global Key Manufacturers of Recombinant Human Insulin, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 28. Global Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 29. Global Recombinant Human Insulin Sales Share by Type (2019-2024)

Table 30. Global Recombinant Human Insulin Sales Share by Type (2025-2030)

Table 31. Global Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Recombinant Human Insulin Revenue Share by Type (2019-2024)

Table 34. Global Recombinant Human Insulin Revenue Share by Type (2025-2030)

Table 35. Recombinant Human Insulin Price by Type (2019-2024) & (USD/mg)

Table 36. Global Recombinant Human Insulin Price Forecast by Type (2025-2030) & (USD/mg)

Table 37. Global Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 38. Global Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 39. Global Recombinant Human Insulin Sales Share by Application (2019-2024)

Table 40. Global Recombinant Human Insulin Sales Share by Application (2025-2030)

Table 41. Global Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Recombinant Human Insulin Revenue Share by Application (2019-2024)

Table 44. Global Recombinant Human Insulin Revenue Share by Application (2025-2030)

Table 45. Recombinant Human Insulin Price by Application (2019-2024) & (USD/mg)

Table 46. Global Recombinant Human Insulin Price Forecast by Application (2025-2030) & (USD/mg)

Table 47. US & Canada Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 48. US & Canada Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 49. US & Canada Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 52. US & Canada Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 53. US & Canada Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Recombinant Human Insulin Sales by Country (2019-2024) & (g)

Table 59. US & Canada Recombinant Human Insulin Sales by Country (2025-2030) & (g)

Table 60. Europe Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 61. Europe Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 62. Europe Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 65. Europe Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 66. Europe Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Recombinant Human Insulin Sales by Country (2019-2024) & (g)

Table 72. Europe Recombinant Human Insulin Sales by Country (2025-2030) & (g)

Table 73. China Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 74. China Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 75. China Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 78. China Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 79. China Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 82. Asia Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 83. Asia Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 86. Asia Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 87. Asia Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Recombinant Human Insulin Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Recombinant Human Insulin Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Recombinant Human Insulin Sales by Region (2019-2024) & (g)

Table 93. Asia Recombinant Human Insulin Sales by Region (2025-2030) & (g)

Table 94. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2019-2024) & (g)

Table 95. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Type (2025-2030) & (g)

Table 96. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2019-2024) & (g)

Table 99. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Application (2025-2030) & (g)

Table 100. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Recombinant Human Insulin Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2019-2024) & (g)

Table 106. Middle East, Africa and Latin America Recombinant Human Insulin Sales by Country (2025-2030) & (g)

Table 107. Akron Biotech Company Information

Table 108. Akron Biotech Description and Major Businesses

Table 109. Akron Biotech Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 110. Akron Biotech Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Akron Biotech Recent Developments

Table 112. Wockhardt Company Information

Table 113. Wockhardt Description and Major Businesses

Table 114. Wockhardt Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 115. Wockhardt Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Wockhardt Recent Developments

Table 117. Dance Biopharm Company Information

Table 118. Dance Biopharm Description and Major Businesses

Table 119. Dance Biopharm Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 120. Dance Biopharm Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Dance Biopharm Recent Developments

Table 122. Novo Nordisk Company Information

Table 123. Novo Nordisk Description and Major Businesses

Table 124. Novo Nordisk Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 125. Novo Nordisk Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Novo Nordisk Recent Developments

Table 127. Gan & Lee Company Information

Table 128. Gan & Lee Description and Major Businesses

Table 129. Gan & Lee Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 130. Gan & Lee Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Gan & Lee Recent Developments

Table 132. United Laboratories Company Information

Table 133. United Laboratories Description and Major Businesses

Table 134. United Laboratories Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 135. United Laboratories Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. United Laboratories Recent Developments

Table 137. Dongbro Pharmaceuticri Company Information

Table 138. Dongbro Pharmaceuticri Description and Major Businesses

Table 139. Dongbro Pharmaceuticri Recombinant Human Insulin Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2019-2024)

Table 140. Dongbro Pharmaceuticri Recombinant Human Insulin Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Dongbro Pharmaceuticri Recent Developments

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Recombinant Human Insulin Distributors List

Table 145. Recombinant Human Insulin Customers List

Table 146. Recombinant Human Insulin Market Trends

Table 147. Recombinant Human Insulin Market Drivers

Table 148. Recombinant Human Insulin Market Challenges

Table 149. Recombinant Human Insulin Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Human Insulin Product Picture

Figure 2. Global Recombinant Human Insulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Recombinant Human Insulin Market Share by Type in 2023 & 2030

Figure 4. Type I Product Picture

Figure 5. Type II Product Picture

Figure 6. Global Recombinant Human Insulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Recombinant Human Insulin Market Share by Application in 2023 & 2030

Figure 8. Type 1 Diabetes Mellitus

Figure 9. Type 2 Diabetes Mellitus

Figure 10. Recombinant Human Insulin Report Years Considered

Figure 11. Global Recombinant Human Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Recombinant Human Insulin Revenue 2019-2030 (US$ Million)

Figure 13. Global Recombinant Human Insulin Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Recombinant Human Insulin Revenue Market Share by Region (2019-2030)

Figure 15. Global Recombinant Human Insulin Sales 2019-2030 ((g)

Figure 16. Global Recombinant Human Insulin Sales Market Share by Region (2019-2030)

Figure 17. US & Canada Recombinant Human Insulin Sales YoY (2019-2030) & (g)

Figure 18. US & Canada Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)

Figure 19. Europe Recombinant Human Insulin Sales YoY (2019-2030) & (g)

Figure 20. Europe Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)

Figure 21. China Recombinant Human Insulin Sales YoY (2019-2030) & (g)

Figure 22. China Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Asia (excluding China) Recombinant Human Insulin Sales YoY (2019-2030) & (g)

Figure 24. Asia (excluding China) Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Middle East, Africa and Latin America Recombinant Human Insulin Sales YoY (2019-2030) & (g)

Figure 26. Middle East, Africa and Latin America Recombinant Human Insulin Revenue YoY (2019-2030) & (US$ Million)

Figure 27. The Recombinant Human Insulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 28. The Top 5 and 10 Largest Manufacturers of Recombinant Human Insulin in the World: Market Share by Recombinant Human Insulin Revenue in 2023

Figure 29. Global Recombinant Human Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 30. Global Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 31. Global Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 32. Global Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 33. Global Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 34. US & Canada Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 35. US & Canada Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 36. US & Canada Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 37. US & Canada Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Recombinant Human Insulin Revenue Share by Country (2019-2030)

Figure 39. US & Canada Recombinant Human Insulin Sales Share by Country (2019-2030)

Figure 40. U.S. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 41. Canada Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 42. Europe Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 43. Europe Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 44. Europe Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 45. Europe Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 46. Europe Recombinant Human Insulin Revenue Share by Country (2019-2030)

Figure 47. Europe Recombinant Human Insulin Sales Share by Country (2019-2030)

Figure 48. Germany Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 49. France Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 50. U.K. Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 51. Italy Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 52. Russia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 53. China Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 54. China Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 55. China Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 56. China Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 57. Asia Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 58. Asia Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 59. Asia Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 60. Asia Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 61. Asia Recombinant Human Insulin Revenue Share by Region (2019-2030)

Figure 62. Asia Recombinant Human Insulin Sales Share by Region (2019-2030)

Figure 63. Japan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 64. South Korea Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 65. China Taiwan Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 66. Southeast Asia Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 67. India Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 68. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Type (2019-2030)

Figure 69. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Recombinant Human Insulin Sales Market Share by Application (2019-2030)

Figure 71. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Market Share by Application (2019-2030)

Figure 72. Middle East, Africa and Latin America Recombinant Human Insulin Revenue Share by Country (2019-2030)

Figure 73. Middle East, Africa and Latin America Recombinant Human Insulin Sales Share by Country (2019-2030)

Figure 74. Brazil Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 75. Mexico Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 76. Turkey Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 77. Israel Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 78. GCC Countries Recombinant Human Insulin Revenue (2019-2030) & (US$ Million)

Figure 79. Recombinant Human Insulin Value Chain

Figure 80. Recombinant Human Insulin Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Recombinant Insulin Market Research Report 2024

Global Human Insulin Delivery System Market Insights Forecast to 2030

Global Human Insulin Drugs Market Research Report 2025

Global Recombinant Insulin Analogue Market Research Report 2024

Global Human Insulin Regular Market Research Report 2025

Global Human Insulin Injections Market Research Report 2024

Global Insulin API Market Insights Forecast to 2030

Global Mixed Recombinant Human Insulin Injection Market Research Report 2024

Global Fast acting Human Insulin Market Research Report 2024

Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030

Global Recombinant Human Growth Hormone Market Research Report 2025

Global Insulin Raw Material Market Research Report 2025

Global Premixed Human Insulin Market Research Report 2024

Global Insulin Preparation Market Research Report 2025

Global Recombinant Insulin Lispro Injection Market Research Report 2024

Insulin Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insulin Management System Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions